Morula IVF Indonesia
Morula IVF Indonesia (PT Morula Indonesia) is the largest fertility clinic chain in Indonesia, operating 15+ ART clinics that deliver IVF, IUI, advanced genetic testing, and fertility preservation services to infertile couples and medical tourists across the archipelago.
- Company typePrivate
- Founded1997
- HeadquartersJakarta, Indonesia
- Headcount101–250
- GTM typeB2C
- OfferingServices
What Morula IVF Indonesia does
Morula IVF Indonesia, legally PT Morula Indonesia, is the largest fertility clinic chain in Indonesia, founded in 1997 as part of the Bundamedik Healthcare System (BMHS). The company operates a network of 15+ directly operated and hospital-partnered clinic locations across major Indonesian cities including Jakarta, Surabaya, Bali (Nusa Dua), Yogyakarta, Makassar, Bandung, Padang, Pontianak, and recently expanded into Bogor, NTT (Kupang), and Manado (North Sulawesi). It serves couples experiencing infertility, patients seeking elective fertility preservation, and a medical-tourism segment drawn from China, France, the Netherlands, Russia, the United States, Japan, and Australia.
The core service portfolio is built on Assisted Reproductive Technology (ART), with IVF (bayi tabung) and IUI (inseminasi buatan) as foundational offerings and a suite of advanced laboratory add-ons: PGT-A and PGT-M for embryo genetic screening, IMSI for high-magnification sperm selection (up to 6,000x), PICSI for physiological sperm selection, and PRP treatments for endometrial and ovarian rejuvenation. The company claims a 77% pregnancy success rate in patients under 35 using PGT-A and reports more than 10,000 babies born through its programs across 25 years, with nearly 6,000 IVF cycles conducted in 2022. Per PERFITRI 2020 data cited by Morula, 1 in 2 IVF babies born in Indonesia originate from Morula clinics.
Revenue is generated through professional service fees across IVF cycles, IUI, fertility examinations, egg freezing, and add-on genetic and laboratory procedures, supplemented by a medical-tourism segment (10-15% of patients) concentrated at the Nusa Dua wellness destination. Go-to-market is sales-led through direct clinic appointments booked via WhatsApp (MIA chatbot), website, walk-ins, and community events, with financing accessibility extended through partnerships with PermataBank (sharia-based) and Akseleran (P2P lending). Distribution is augmented by hospital collaborations such as RS Azra, RS Indriati Solo Baru, Arra Fertility Clinic, and Klinik Pelita Kasih Tondano that extend reach into previously underserved regions. In April 2024, Hong Kong-listed Jinxin Fertility Group Limited (JXR) took a significant equity stake, adding strategic capital and an international ART operator as a shareholder.
Morula IVF Indonesia firmographics
Firmographics- Name
- Morula IVF Indonesia
- Legal name
- PT Morula Indonesia
- Website
- https://morulaivf.co.id
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Morula IVF Indonesia (PT Morula Indonesia) is the largest fertility clinic chain in Indonesia, operating 15+ ART clinics that deliver IVF, IUI, advanced genetic testing, and fertility preservation services to infertile couples and medical tourists across the archipelago.
- Ownership category
- akta.pro rank
Morula IVF Indonesia industry classification
Industry- Product category
- Fertility and Reproductive Healthcare Services
- NAICS
- Family Planning Centers (621410)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)
- akta.pro secondary industries
- Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Fertility/IVF & Reproductive Tourism Agencies (THAKAIAF)
Keywords
Where Morula IVF Indonesia is headquartered
LocationHeadquarters
- HQ city
- Jakarta
- HQ country
- Indonesia
- HQ region
- Asia
Offices16 records
Markets served
Morula IVF Indonesia business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Others
Revenue model
- Fertility Treatment Services: Morula IVF Indonesia generates revenue through providing fertility treatments including IVF (In Vitro Fertilization), IUI (Intrauterine Insemination), fertility examinations, egg freezing, and other assisted reproductive technology services. The company offers various package options for different treatments and provides financing partnerships for customers requiring payment assistance.
- Medical Tourism: Approximately 10-15% of patients are medical tourists coming from outside provinces, islands, and international countries including China, France, Netherlands, Russia, America, Japan, and Australia, contributing to revenue through international patient services.
Go-to-market motion1 record
Distribution channels6 records
Marketing channels10 records
Morula IVF Indonesia product offering
Product offeringCore offering
Morula IVF Indonesia is a network of fertility clinics operating in 15+ cities across Indonesia, delivering assisted reproductive technology (ART) services such as IVF (bayi tabung), IUI (inseminasi buatan), fertility examinations, and egg freezing, complemented by advanced genetic testing (PGT-A, PGT-M), sperm selection technologies (IMSI, PICSI), and PRP rejuvenation treatments. The company serves individual couples with fertility challenges, offers women fertility preservation, and caters to medical tourism patients from international locations seeking high success rates.
Product overview
Morula IVF Indonesia operates as a network of fertility clinics across Indonesia, functioning as both the core healthcare service brand and the parent organization. The main product portfolio centers on Assisted Reproductive Technology (ART) services, with IVF – Bayi Tabung (In Vitro Fertilization) as the flagship core service, complemented by IUI – Inseminasi Buatan (Intrauterine Insemination) and Pemeriksaan Kesuburan (Fertility Examination) as foundational diagnostic and treatment services. Advanced add-on technologies include PGT-A (Pre-Implantation Genetic Testing for Aneuploidy) and PGT-M for embryo genetic screening, IMSI and PICSI for sperm selection, and PRP treatments for endometrial and ovarian rejuvenation. The network extends across 13+ cities in Indonesia including Jakarta, Surabaya, Bali (Nusa Dua), Tangerang, Ciputat, Yogyakarta, Makassar, Pontianak, Bandung, Margonda, Padang, with newest locations in Manado, NTT (Kupang), and Bogor, supported by digital tools (Kalkulator Kehamilan and Kalkulator Masa Subur) and educational content (Morula Life magazine). Bundamedik Healthcare System subsidiary since 1997.
Differentiator
Problem solved
Functional benefit
Brands
- Morula Life: Monthly magazine/publication by Morula IVF Indonesia providing articles on fertility, IVF, and inspirational patient stories.
- Morula Wellness POD (Cocoon Therapy)
Products and services
- IVF – Bayi Tabung (In Vitro Fertilization) In vitro fertilization (IVF), or bayi tabung, is an Assisted Reproductive Technology (ART) procedure that helps couples facing difficulties conceiving. Eggs are fertilized with sperm outside the body in a laboratory setting, and resulting embryos are transferred into the uterus.
- IUI – Inseminasi Buatan (Intrauterine Insemination) Intrauterine insemination (IUI) procedure where processed sperm is directly inserted into the woman's uterus to increase pregnancy chances, commonly used for mild infertility cases and timed with natural ovulation or hormonal stimulation.
- Pemeriksaan Kesuburan (Fertility Examination) Series of medical procedures to help couples experiencing difficulty conceiving, including ovulation induction and menstrual cycle monitoring. Detects optimal ovulation timing and stimulates release of mature eggs.
- Egg Freezing (Fertility Preservation) Fertility preservation service allowing women to freeze their eggs for future use, available as promotional packages across all Morula clinic locations in Indonesia.
- PGT-A (Pre-Implantation Genetic Testing for Aneuploidy) Advanced genetic testing technology that detects chromosomal abnormalities in embryos to prevent miscarriage, reduce pregnancy failure rates, and detect Down syndrome risk. Reported to increase pregnancy success rates to 77% in patients under 35.
- PGT-M (Pre-Implantation Genetic Testing for Monogenic) Diagnostic procedure for detecting single-gene mutations inherited from parents. Important for couples with family history of genetic disorders such as Thalassemia, Spinal Muscular Atrophy, and Cystic Fibrosis.
- IMSI (Intracytoplasmic Morphologically Selected Sperm Injection) Sperm selection method using magnification up to 6,000x to ensure selection of highest quality sperm for IVF, improving fertilization success rates and healthy pregnancy outcomes.
- PICSI (Physiological Intracytoplasmic Sperm Injection) Sperm selection technology that chooses mature sperm before injection into the egg, used in conjunction with IVF to improve fertilization success rates.
- PRP (Platelet Rich Plasma) - Endometrium and Ovarium Two types of PRP treatment: Endometrium PRP separates platelet-rich plasma to improve uterine lining quality with growth factors for tissue regeneration; Ovarium PRP improves egg quality in women with fertility issues. Both have minimal allergic reaction risk.
- Morula Wellness POD (Cocoon Therapy) Infrared-based hyperthermic fitness therapy solution aimed at detoxification and lymphatic drainage, offered as part of wellness services for fertility patients.
Quantifiable outcome
- 77% success rate with PGT-A for patients under 35 years old
- +5 more outcomes
Companies that use Morula IVF Indonesia
Customer profileNamed customers8 records
Segments3 records
Ideal customer profiles2 records
Morula IVF Indonesia technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
Morula IVF Indonesia partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core, flagship, supporting, regional and minor.
- Rumah Sakit AzracoreCollaboration to bring the first Morula IVF fertility clinic to Kota Bogor, Kabupaten Bogor, Depok, Sukabumi, and surrounding areas. Located at Jalan Raya Pajajaran Nomor 219, Kota Bogor, this partnership addresses the lack of fertility services in the region and brings hope to couples who previously had to travel far for quality care.
- Klinik Pelita Kasih TondanocoreCollaboration to bring the first Morula IVF baby tabung service to Kota Manado and North Sulawesi region. This partnership addresses the need for couples in Sulawesi Utara to travel far for fertility treatment, providing accessible local access to quality IVF services.
- Arra Fertility CliniccoreCollaboration to launch the first baby tabung (IVF) service in NTT (Nusa Tenggara Timur) at Kota Kupang. Located at Jalan WJ Lalamentik, this partnership makes fertility services more accessible to couples in East Indonesia who previously had to travel to major cities for treatment.
- Bundamedik Healthcare System (BMHS)flagshipPart of Bundamedik Healthcare System (BMHS), one of Indonesia's leading healthcare groups providing integrated fertility and medical services across the archipelago.
- PermataBanksupportingSharia-based financing partnership through PermataKTA iB Multiguna product, providing flexible financing solutions for couples seeking IVF treatments. This partnership helps make fertility services more accessible through installment payment options.
- Jinxin Fertility Group Limited (JXR)coreStrategic partnership with Jinxin Fertility Group Limited through share purchase agreement, with JXR becoming a significant shareholder in Morula following equity investment completion. The collaboration aims to leverage expertise in Assisted Reproductive Technology (ART) to expand IVF services in Indonesia and Southeast Asia.
- Rumah Sakit Indriati Solo BaruregionalPartnership to launch Morula IVF services at RS Indriati Solo Baru with Women Specialist Care Center. The collaboration addresses the 15-20% infertility rate in Central Java, particularly Solo area, providing accessible fertility services to couples in the region.
- AkseleransupportingFinancing partnership with fintech peer-to-peer lending platform PT. Akseleran Keuangan Inklusif Indonesia, launching flexible and safe financing facilities for IVF program treatments to improve accessibility.
- Dharma Wanita Persatuan Setjen DPD RIminorCommunity education partnership holding reproductive health seminar in collaboration with Dharma Wanita Persatuan (DWP) Setjen DPD RI and Poliklinik DPD RI for International Kartini Day.
- Komunitas Perempuan Sadar Vagina (PSV)minorCommunity partnership for virtual public seminar on women's reproductive health organized by Morula IVF Jakarta in collaboration with PSV community.
- RSIA SentosaregionalGrand opening and relocation of Morula IVF Makassar to RSIA Sentosa with comprehensive wellness and fertility center concept, enhancing service capabilities in South Sulawesi.
Scale indicators12 records
Recent moves13 records
Expansion highlights6 records
Morula IVF Indonesia competitors and assessment
Company assessmentDirect peers
- Jinxin Fertility Group Limited: HK-listed IVF chain that became a significant shareholder in Morula in April 2024; comparable as a multi-country ART operator with overlapping technology portfolio (PGT, IMSI) and SE Asia expansion ambitions.
- TMC Fertility (TMC Life Sciences): Malaysia's leading fertility chain offering IVF, IUI, PGT, and fertility preservation; comparable as a SE Asia-based multi-clinic ART operator targeting both domestic and medical tourism patients.
- Alpha IVF & Women's Specialist: Malaysian fertility specialist with strong PGT and advanced ART technology focus; comparable to Morula's premium, technology-led positioning in SE Asia.
- Raffles Fertility Centre (Raffles Medical Group): Singapore-based fertility service within Raffles Medical Group, competing for SE Asia medical tourism patients with similar international accreditation standards.
- Thomson Fertility Centre (Thomson Medical): Singapore fertility provider within Thomson Medical; comparable multi-clinic ART operator targeting regional medical tourism patients including from Indonesia.
- Safe Fertility Center: Thailand-based IVF group with advanced ART capabilities and a strong international patient base; directly comparable to Morula on medical tourism positioning and technology mix.
Broad incumbents
- Genea Fertility: Established Australian fertility operator with proprietary technology; comparable through RTAC accreditation and PGT/ICSI capabilities similar to Morula's technology stack.
- Monash IVF Group: Australian-listed IVF operator with international footprint; comparable as a scaled fertility provider with RTAC-grade accreditation, serving as a clinical reference point for Indonesian specialists trained there.
Others
- Bundamedik Healthcare System (BMHS): Parent healthcare conglomerate of which Morula is a subsidiary; relevant as the broader corporate parent providing hospital and ancillary service infrastructure that supports Morula's clinic operations.
Regional players
- Bangkok Dindekan Medical Clinic: Thailand fertility specialist with strong international patient flow; comparable to Morula on medical tourism value proposition for SE Asia and Indonesian patients.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Morula IVF Indonesia social profiles
Digital presenceMorula IVF Indonesia compliance and trust
Trust signalCompliance1 record
Morula IVF Indonesia financial estimates
Financial estimateRevenue estimate
Valuation estimate
Morula IVF Indonesia leadership team
Management profileNumber of profiles
Profiles5 records
Morula IVF Indonesia subsidiaries and ownership
Company hierarchySubsidiaries8 records
Morula IVF Indonesia funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Morula IVF Indonesia M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Morula IVF Indonesia
What does Morula IVF Indonesia do?
Morula IVF Indonesia is a network of fertility clinics operating in 15+ cities across Indonesia, delivering assisted reproductive technology (ART) services such as IVF (bayi tabung), IUI (inseminasi buatan), fertility examinations, and egg freezing, complemented by advanced genetic testing (PGT-A, PGT-M), sperm selection technologies (IMSI, PICSI), and PRP rejuvenation treatments. The company serves individual couples with fertility challenges, offers women fertility preservation, and caters to medical tourism patients from international locations seeking high success rates.
Is Morula IVF Indonesia a public or private company?
Morula IVF Indonesia is a private company. It is classified as corporate owned and is currently operating.
When was Morula IVF Indonesia founded?
Morula IVF Indonesia was founded in 1997. It employs 101 to 250 people.
Where is Morula IVF Indonesia based?
Morula IVF Indonesia is headquartered in Jakarta, Indonesia, in the Asia region.
How does Morula IVF Indonesia make money?
Two revenue lines are on record. Fertility Treatment Services are the primary driver. The others are medical Tourism.
Who are Morula IVF Indonesia's main competitors?
Direct peers on record are Jinxin Fertility Group Limited, TMC Fertility (TMC Life Sciences), Alpha IVF & Women's Specialist, Raffles Fertility Centre (Raffles Medical Group), Thomson Fertility Centre (Thomson Medical) and Safe Fertility Center. Broad incumbents are Genea Fertility and Monash IVF Group. Bundamedik Healthcare System (BMHS) is listed as an others. Bangkok Dindekan Medical Clinic is listed as a regional player.
Does Morula IVF Indonesia have an API?
No public API is recorded for Morula IVF Indonesia.
What industry is Morula IVF Indonesia in?
Morula IVF Indonesia's product category is Fertility and Reproductive Healthcare Services. Its primary akta.pro industry code is HLAFAJAD, Fertility, Reproductive Endocrinology & IVF Centers, with a secondary code of HLAAALAJ, Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening). Its NAICS code is 621410 and its SIC code is 8011.